Source: BMC Cancer. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MERKEL, Christian A. et al. Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6. BMC Cancer, v. 10, n. 316, 2010Tradução . . Disponível em: https://doi.org/10.1186/1471-2407-10-316. Acesso em: 01 out. 2024.APA
Merkel, C. A., Soares, R. B. da S., Carvalho, A. C. P. V. de, Zanatta, D. B., Bajgelman, M. C., Fratini, P., et al. (2010). Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6. BMC Cancer, 10( 316). doi:10.1186/1471-2407-10-316NLM
Merkel CA, Soares RB da S, Carvalho ACPV de, Zanatta DB, Bajgelman MC, Fratini P, Costanzi-Strauss E, Strauss BE. Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6 [Internet]. BMC Cancer. 2010 ; 10( 316):[citado 2024 out. 01 ] Available from: https://doi.org/10.1186/1471-2407-10-316Vancouver
Merkel CA, Soares RB da S, Carvalho ACPV de, Zanatta DB, Bajgelman MC, Fratini P, Costanzi-Strauss E, Strauss BE. Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6 [Internet]. BMC Cancer. 2010 ; 10( 316):[citado 2024 out. 01 ] Available from: https://doi.org/10.1186/1471-2407-10-316